A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Columnist Sam Kirton and his wife go with the flow when changes are necessary, such as rescheduling a Halloween party to the advent of spring.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

While every person's journey with PF is unique, columnist Sam Kirton stresses the importance of support groups for patients and caregivers.

Weight loss is a recurring topic during my medical appointments, and I frequently discuss it with my transplant team. I wrote about this a couple years ago in a column titled “Using Ozempic in hopes ...

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Enrollment is now complete in a Phase 2b clinical trial, dubbed CORAL, that’s testing nalbuphine extended-release (ER) tablets — planned to be marketed as Haduvio — in people with idiopathic pulmonary ...